✦ LIBER ✦

Immune-mediated disease and secondary failure to oral therapy in type 2 diabetes mellitus

✍ Scribed by Larissa Avilés-Santa; Noel Maclaren; Philip Raskin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secondary Failure Rates Associated with

✍ Mr. Dean T. Eurich; Dr. Scot H. Simpson; Dr. Sumit R. Majumdar; Dr. Jeffrey A. J 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Secondary failure of oral antidiabetic a

✍ Mirouze, J.; Augustin-Pascalis, I. 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 496 KB

Cardiovascular risk factors and diseases

✍ Joëlle A. Erkens; Ron M.C. Herings; Ronald P. Stolk; José A. Spoelstra; Diederic 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Rates of progression to end stage renal

✍ Bruce, R. ;Williams, L. ;Cundy, T. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB

Unmet needs among patients with Type 2 d

✍ Pitocco, D.; Valle, D.; Rossi, A.; Gentilella, R. 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 92 KB

Role of Lifestyle and Oral Anti-Diabetic

✍ M. Angelyn Bethel; Robert M. Califf 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 152 KB